Search the Newsreel

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction

Should You Worry About Trump Media Insider Activity as the Stock Falls? Here's How to Read It

Kevin McGurn, the company's interim CEO, reported the disposition of 16,509 shares of Trump Media & Technology Group Corp. (NASDAQ:DJT) on August 13, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value $137,520 Shares sold 16,509 Post-transaction shares (directly held) …

ResMed Inc. stock falls Friday, underperforms market

ResMed Inc. (RMD) stock decreased by 1.01% to $224.46 on Friday, underperforming the broader market as the S&P 500 and Dow Jones Industrial Average also experienced declines. This fall ended a four-day winning streak for the company's shares.

Digital Channels Accounted for 47% of MediaCo’s Q2 Ad Revenue

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …

Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary

Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …

MediaCo Q2 Revenue Rises 9% to $34 Million

MediaCo Holding Inc. (Nasdaq: MDIA) grows Q2 revenue 9% but net loss widens

Adagio Medical Receives Nasdaq Listing Deficiency Notice

ENvue Medical, Inc. SEC Filing (Aug 14, 2026)

ENvue Medical, Inc. has filed a Form 12b-25 Notification of Late Filing for its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The company stated that additional time is needed to prepare, compile, and analyze supporting documentation to complete its …

CervoMed (CRVO): RA Capital discloses 8.6% stake through 1.27M warrant shares

RA Capital Management and its affiliated funds have disclosed an 8.6% beneficial ownership stake in CervoMed Inc. (CRVO), primarily through warrants exercisable for 1,266,143 shares of common stock. This disclosure, based on a SCHEDULE 13G/A filing, indicates that RA Capital, along with Peter Kolchinsky …

Darwin Global updates Insmed Inc (INSM) ownership, reporting 3.0% beneficial stake

Darwin Global Management, Ltd., along with its Chief Investment Officer Dr. Abhishek Trehan and Darwin Global Master Fund Ltd., has reported a beneficial ownership of 3.0% in Insmed Inc. common stock, totaling 6,431,163 shares. This stake is based on 216,752,451 shares outstanding as of …

Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake

Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …

Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Adagio Medical Holdings (ADGM) received a Nasdaq deficiency notice on August 13, 2026, for failing to meet the Listing Rule 5550(b)(1) requirement of at least $2.5 million in stockholders' equity, as their June 30, 2026 Form 10-Q reported equity of $(415,000). The notice does …

MediaCo Holding Inc. (MDIA) grows digital revenue but faces going-concern and covenant risks

Medpace CEO August J. Troendle sells $7.1m in company stock

Medpace Holdings Inc. CEO August J. Troendle recently sold approximately $7.1 million worth of company stock over two days in August. These sales occurred after Medpace shares surged 36% in six months, though an InvestingPro analysis suggests the stock is currently overvalued. The company …

PAVM Q2 FY2026 earnings call

PAVmed reported significantly narrowed losses in Q2 FY2026, with a GAAP net loss of $5.5 million compared to $12.3 million in the prior year, and a non-GAAP net loss of $1.7 million. The company highlighted progress across its portfolio, including expanded reimbursement for Lucid …

IceCure Medical (ICCM) expands 2024 employee share incentive reserve

IceCure Medical Ltd. has increased the ordinary shares reserved for its 2024 Employee Equity Incentive Plan by 2,500,000, bringing the new total to 2,612,667 ordinary shares. This expansion, approved by the board on August 11, 2026, provides additional capacity for future equity awards to …

OneMedNet (ONMD) warns on going concern as cash runs low and losses widen

Mobia Medical (MOBI) gets 11.1% ownership filing from Green Park & Golf group

Green Park & Golf Ventures II, LLC and affiliated entities have reported a beneficial ownership of 11.1% in Mobia Medical, Inc. (MOBI), totaling 3,684,409 shares. This stake is held across numerous LLCs, with managers Clay M. Heighten, MD, Carl D. Soderstrom, and Gilbert G. …

Pediatrix Medical Group (MD) director receives 472-share restricted stock grant

John M. Starcher Jr., a director at Pediatrix Medical Group (MD), was granted 472 restricted shares of common stock on August 12, 2026. These shares, valued at $26.50 each, are part of the company's incentive compensation plan and will vest on May 7, 2027. …

Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings

Pediatrix Medical Group director Thomas McEachin was granted 472 restricted shares of common stock on August 12, 2026, valued at $26.50 per share, under the company's incentive plan. These shares will vest on May 7, 2027. Following this transaction, his direct holdings increased to …

Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone

Pediatrix Medical Group (MD) director Guy P. Sansone received an equity award of 472 restricted shares on August 12, 2026, priced at $26.50 per share. These shares, granted under the company's Second Amended and Restated 2008 Incentive Compensation Plan, will vest on May 7, …

Medifast (MED): Citadel entities and Kenneth Griffin disclose sub‑5% ownership stake

Citadel entities, including Citadel Securities LLC and Citadel Advisors LLC, along with Kenneth Griffin, have filed an amended Schedule 13G disclosing beneficial ownership of Medifast (MED) common stock. The filing indicates that each reporting person holds less than 5% of Medifast's outstanding shares, with …

BIGTK Hisse Yorumları (BIG MEDYA TEKNOLOJI Güncel Yorumlar)

Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill

Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax

Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares

Profound Medical CFO Steps Down; Controller Takes Interim Role

Profound Medical (NASDAQ: PROF; TSX: PRN) has announced a management change, with Matthew Sobczyk, formerly Corporate Controller, promoted to Interim Chief Financial Officer. He succeeds Rashed Dewan, who has stepped down but will remain on a short-term consulting contract to ensure a smooth transition. …

Galmed Pharmaceuticals (GLMD) to implement 1-for-8 reverse share split in August 2026

Galmed Pharmaceuticals (GLMD) has announced a 1-for-8 reverse share split, consolidating its ordinary shares, with post-split trading expected to begin on August 19, 2026, on the Nasdaq Capital Market. This action will reduce the number of outstanding shares from 8,332,518 to approximately 1,041,565 and …

Baker Bros. Advisors (RVMD) discloses 11.4M-share position in Revolution Medicines

Baker Bros. Advisors LP and related entities have reported a passive ownership stake of 5.3% in Revolution Medicines, Inc. This translates to beneficial ownership of 11,443,357 shares of common stock, held through investment funds Baker Brothers Life Sciences, L.P. and 667, L.P. The filing …

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership

ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales

Carlsmed Inc. (CARL) has filed a shelf registration to offer up to $250 million in common stock, preferred stock, debt securities, warrants, and units. This filing allows the medical technology company to access capital markets for future funding, with specific terms for each issuance …

Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis

CervoMed (CRVO) holders CVI and Heights report 0% stake in amended filing

CVI Investments, Inc. and Heights Capital Management, Inc. have filed an amended Schedule 13G/A for CervoMed Inc. (CRVO), reporting a 0% beneficial ownership in the company. This filing indicates that both entities collectively hold no shares and possess no voting or dispositive power over …

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …